William F. Symmans, MD, professor of Pathology, The University of Texas MD Anderson Cancer Center, discusses the staging system for patients with breast cancer. 

With the anticipated 8th addition of the staging system, a current question is what is to be expected in the staging setting? A lot of attention has been placed in the post-neoadjuvant staging, discusses Symmans.  

We can anticipate greater clarity for the practicing pathologists and more solid guidelines for defining how to measure tumor burden in the challenging area of breast pathology going forward, explains Symmans. 

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Lynn Sage Breast Cancer Symposium

William F. Symmans, MD, professor of Pathology, The University of Texas MD Anderson Cancer Center, discusses the staging system for patients with breast cancer.

Dr. Symmans on the Staging System for Breast Cancer